{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:01:53Z","timestamp":1791489713572,"version":"4.3.4"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,27]],"date-time":"2016-01-27T00:00:00Z","timestamp":1453852800000},"content-version":"vor","delay-in-days":391,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.jacc.2014.10.052","type":"journal-article","created":{"date-parts":[[2015,1,19]],"date-time":"2015-01-19T15:45:17Z","timestamp":1421682317000},"page":"225-232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":182,"title":["Benefit of Anticoagulation Unlikely in\u00a0Patients With Atrial Fibrillation and\u00a0a\u00a0CHA2DS2-VASc Score of 1"],"prefix":"10.1016","volume":"65","author":[{"given":"Leif","family":"Friberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Skeppholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Ter\u00e9nt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2014.10.052_bib1","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.jacc.2006.07.009","article-title":"ACC\/AHA\/ESC 2006 guidelines for the management of patients with atrial fibrillation","volume":"48","author":"Fuster","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.10.052_bib2","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/eurheartj\/ehq278","article-title":"Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)","volume":"31","author":"Camm","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2014.10.052_bib3","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1093\/europace\/eus305","article-title":"2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation developed with the special contribution of the European Heart Rhythm Association","volume":"14","author":"Camm","year":"2012","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2014.10.052_bib4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cjca.2010.11.015","article-title":"Canadian Cardiovascular Society atrial fibrillation guidelines 2010: etiology and initial investigations","volume":"27","author":"Healey","year":"2011","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jacc.2014.10.052_bib5","first-page":"e3531S","article-title":"Antithrombotic therapy for atrial fibrillation\u2014antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"You","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2014.10.052_bib6","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on Atrial Fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2014.10.052_bib7","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1161\/STROKEAHA.110.590257","article-title":"Identifying patients at high risk for stroke despite anticoagulation: a comparison of contemporary stroke risk stratification schemes in an anticoagulated atrial fibrillation cohort","volume":"41","author":"Lip","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2014.10.052_bib8","doi-asserted-by":"crossref","first-page":"d124","DOI":"10.1136\/bmj.d124","article-title":"Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study","volume":"342","author":"Olesen","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2014.10.052_bib9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1540-8167.2010.01858.x","article-title":"Stroke risk stratification in a \u201creal-world\u201d elderly anticoagulated atrial fibrillation population","volume":"22","author":"Poli","year":"2011","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2014.10.052_bib10","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.ijcard.2012.10.052","article-title":"Validation of contemporary stroke and bleeding risk stratification scores in non-anticoagulated Chinese patients with atrial fibrillation","volume":"168","author":"Guo","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2014.10.052_bib11","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1093\/eurheartj\/ehr488","article-title":"Evaluation of risk stratification schemes for ischaemic stroke and\u00a0bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation Cohort Study","volume":"33","author":"Friberg","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2014.10.052_bib12","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/eurheartj\/ehs314","article-title":"The\u00a0CHA2DS2-VASc score identifies those patients with\u00a0atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy","volume":"34","author":"Coppens","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2014.10.052_bib13","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.ijcard.2013.02.003","article-title":"Gulf Survey of Atrial Fibrillation Events I. Assessment of stroke risk in Middle Eastern patients with atrial fibrillation: the Gulf Safe Registry","volume":"168","author":"Apostolakis","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2014.10.052_bib14","doi-asserted-by":"crossref","first-page":"297","DOI":"10.7326\/0003-4819-151-5-200909010-00003","article-title":"The net clinical benefit of warfarin anticoagulation in atrial fibrillation","volume":"151","author":"Singer","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2014.10.052_bib15","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1160\/TH11-05-0364","article-title":"Risks of\u00a0thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: a\u00a0net clinical benefit analysis using a 'real world' nationwide cohort study","volume":"106","author":"Olesen","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacc.2014.10.052_bib16","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1161\/CIRCULATIONAHA.111.055079","article-title":"Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish Atrial Fibrillation Cohort Study","volume":"125","author":"Friberg","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2014.10.052_bib17","unstructured":"The Swedish Board of Health and Welfare. Quality of coding in the national Swedish Patient register, hospital care 2008. Only available in Swedish [Socialstyrelsen. Kodningskvalitet i patientsregistret, slutenv\u00e5rd 2008]. Socialstyrelsen 2010.\u00a0Available at:\u00a0http:\/\/www.socialstyrelsen.se\/publikationer2010\/2010-6-27. Accessed November 7,\u00a02014."},{"key":"10.1016\/j.jacc.2014.10.052_bib18","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s10654-009-9404-1","article-title":"Atrial fibrillation in the Malm\u00f6 Diet and Cancer study: a study of occurrence, risk factors and diagnostic validity","volume":"25","author":"Smith","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.jacc.2014.10.052_bib19","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/1471-2458-11-450","article-title":"External review and validation of the Swedish national inpatient register","volume":"11","author":"Ludvigsson","year":"2011","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jacc.2014.10.052_bib20","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1159\/000345953","article-title":"Refinement of Swedish administrative registers to\u00a0monitor stroke events on the national level","volume":"40","author":"Koster","year":"2013","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.jacc.2014.10.052_bib21","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1747-4949.2010.00557.x","article-title":"The Riks-Stroke story: building a sustainable national register for quality assessment of stroke care","volume":"6","author":"Asplund","year":"2011","journal-title":"Int J Stroke"},{"key":"10.1016\/j.jacc.2014.10.052_bib22","unstructured":"Riks-Stroke. Annual report 2012. Available at: http:\/\/www.riksstroke.org\/wp-content\/uploads\/2014\/02\/Riks-Strokes_Arsrapport-2012.pdf. Accessed June 19,\u00a02014."},{"key":"10.1016\/j.jacc.2014.10.052_bib23","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S1474-4422(07)70248-X","article-title":"A\u00a0transient ischaemic attack clinic with round-the-clock access (SOS-TIA): feasibility and effects","volume":"6","author":"Lavallee","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jacc.2014.10.052_bib24","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1161\/CIRCOUTCOMES.110.958108","article-title":"Moving the tipping point: the decision to anticoagulate patients with atrial fibrillation","volume":"4","author":"Eckman","year":"2011","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2014.10.052_bib25","doi-asserted-by":"crossref","first-page":"e3522","DOI":"10.1136\/bmj.e3522","article-title":"Assessment of female sex as a risk factor in atrial fibrillation in Sweden: nationwide retrospective cohort study","volume":"344","author":"Friberg","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2014.10.052_bib26","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1378\/chest.11-0862","article-title":"Risk factors for stroke and thromboembolism in relation to age amongst patients with atrial fibrillation: the Loire Valley atrial fibrillation project","volume":"141","author":"Olesen","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2014.10.052_bib27","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2014.03.022","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society","volume":"64","author":"January","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.10.052_bib28","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ahj.2011.09.011","article-title":"International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD)","volume":"163","author":"Kakkar","year":"2012","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2014.10.052_bib29","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ahj.2013.12.006","article-title":"Design and rationale of Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation: a global registry program on long-term oral antithrombotic treatment in patients with atrial fibrillation","volume":"167","author":"Huisman","year":"2014","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2014.10.052_bib30","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1160\/TH13-12-1007","article-title":"Differences among western European countries in anticoagulation management of atrial fibrillation. Data from the PREFER IN AF registry","volume":"111","author":"Le Heuzey","year":"2014","journal-title":"Thromb Haemostasis"},{"key":"10.1016\/j.jacc.2014.10.052_bib31","first-page":"606","article-title":"Outcomes registry for better informed treatment of atrial fibrillation: rationale and design of ORBIT-AF","volume":"162","author":"Piccini","year":"2011","journal-title":"Am\u00a0Heart J"},{"key":"10.1016\/j.jacc.2014.10.052_bib32","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.ejheart.2004.12.007","article-title":"The validity of a diagnosis of heart failure in a hospital discharge register","volume":"7","author":"Ingelsson","year":"2005","journal-title":"Eur J Heart Fail"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109714070119?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109714070119?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T02:52:24Z","timestamp":1537930344000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109714070119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0735109714070119"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2014.10.052","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Benefit of Anticoagulation Unlikely in\u00a0Patients With Atrial Fibrillation and\u00a0a\u00a0CHA2DS2-VASc Score of 1","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2014.10.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}